Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stargardt Disease Type 1 (STGD1)”

Showing 6 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04239625
What this trial is testing

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

Who this might be right for
Stargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy+1 more
Alkeus Pharmaceuticals, Inc. 200
Testing effectiveness (Phase 2)Looking for participantsNCT07439887
What this trial is testing

Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease

Who this might be right for
Stargardt Disease
Ray Therapeutics, Inc. 18
Early research (Phase 1)Study completedNCT02230228
What this trial is testing

Phase 1 Safety Study of ALK-001 in Healthy Volunteers

Who this might be right for
Stargardt DiseaseAge-related Macular DegenerationOther Retinal Dystrophies
Alkeus Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT05266014
What this trial is testing

This is a Dose-finding Study Followed by 2-year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt Disease

Who this might be right for
Stargardt Disease
RBP4 Pty Ltd 13
Large-scale testing (Phase 3)Study completedNCT05244304
What this trial is testing

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease

Who this might be right for
Stargardt Disease 1
Belite Bio, Inc 104
Not applicableStudy completedNCT01790958
What this trial is testing

Microcurrent Stimulation to Treat Macular Degeneration

Who this might be right for
Retinal DiseasesStargardt's DiseaseRetinitis Pigmentosa
Retina Institute of Hawaii 50

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation